U.S. regulators to examine testosterone therapy as use by menopausal women rises
The Hindu — Health · 18 Sep 2026
We couldn't retrieve the full article from The Hindu — Health, so this is the available summary.
The lack of a female-specific product creates practical challenges for clinicians, an approved product could provide standardised dosing, labeling and safety-monitoring guidance and potentially improve insurance coverage
Related articles
India · The Hindu — Health · 1 hour agoEbola reminder of urgent need to finish pandemic treaty: WHO chief
Pointing to several recent deadly disease outbreaks, he stressed that completing a pandemic treaty was "about protecting people"
Read full article
India · The Hindu — Health · 2 hours agoVietnam scraps child organ donors proposal after backlash
The newly revised draft still allows living minors to donate regenerative tissue, for bone marrow or stem cell transplants, to family members when no…
Read full article
India · The Hindu — Health · 3 hours agoOocyte racket in Telangana: Women paid ₹20,000 as operators made around ₹3 lakh per cycle
Police probe alleged exploitation of 43 women, including possible forged consent documents and illegal commissions, while examining recruitment networks, payment trails and the role…
Read full article